ERAL1 and breast cancer: As previously demonstrated, B16K1 cells were selected as representative ER-negative tumors because their growth is increased by E2 in vivo similarly to LL2 (lung cancer) and 4T1 (breast cancer) cells, although they do not express ERα and do not proliferate in vitro in response to E2 10.